Pesquisa

Edição
Título
Autores
Nº 16 (2014)
Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa
Verbovoy A., Sharonova L., Akhmerova R.
PDF
(Rus)
Nº 5 (2014)
OSOBENNOSTI SAKhAROSNIZhAYuShchEY TERAPII VO VREMYa BEREMENNOSTI
Arbatskaya N.
PDF
(Rus)
Nº 5 (2014)
VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Abaeva M., Nazhmutdinova P., Ametov A.
PDF
(Rus)
Nº 16 (2013)
Bazal'naya insulinoterapiya: opyt klinicheskoy praktiki
Chernikova N., Ametov A., Antsiferov M.
PDF
(Rus)
Nº 5 (2013)
KLINIChESKIE PREIMUShchESTVA PERVOGO ANALOGA ChELOVEChESKOGO GPP-1 LIRAGLUTIDA PRI LEChENII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA
Demidova I.
PDF
(Rus)
Nº 5 (2013)
SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA
Ruyatkina L., Lomova A., Ruyatkin D.
PDF
(Rus)
Nº 16 (2012)
Khronicheskaya serdechnaya nedostatochnost' u bol'nykh sakharnym diabetom: sovremennye predstavleniya
Ettinger O.
PDF
(Rus)
Nº 16 (2012)
Nevropatiya i prediabet: eti chasy nachinayut tikat' rano
Ametov A., Lysenko M.
PDF
(Rus)
Nº 7 (2012)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antsiferov M.
Nº 3 (2012)
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS
Antsiferov M., Antsiferov M.
Nº 16 (2011)
Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu
Antsiferov M., Antciferov M.
Nº 5 (2011)
CLINICAL AND METABOLIC EFFICIENCY OF DRUG DIBIKOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Severina T., Popkova E., Trel'skaya N., Emel'yanov V., Severina T., Popkova Y., Trelskaya N., Yemelyanov V.
Nº 3 (2011)
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.
Nº 16 (2010)
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N., Petunina N.
Nº 7 (2010)
ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY
Tabeeva G., Azimova Y., Tabeeva G., Azimova Y.
Nº 3 (2010)
Advance - movement forward
Petunina N., Petunina N.
Nº 17 (2009)
OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI
Demidova I., Mel'nikova E., Arbatskaya N., Ignatova N.
Nº 15 (2009)
Insulin resistance and heart diseases: is there a relationship?
Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.
Nº 3 (2009)
Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL
Antsiferov M., Petraneva E., Anciferov M., Petraneva E.
Volume 29, Nº 11/12 (2022)
Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review
Petunina N., Martirosyan N., Valeeva F.
PDF
(Rus)
Volume 29, Nº 4 (2022)
Application of the diabetes screening questionnaire in patients with psoriasis
Morzhanaeva M., Svechnikova E., Shchepkina E., Kuznetsov A.
PDF
(Rus)
Volume 28, Nº 12 (2021)
Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics
Shorokhova P., Baranov V.
PDF
(Rus)
Volume 28, Nº 4 (2021)
Experience of insulin degludec treatment using constant glucose monitoring system (CGMS)
Smirnova E.
PDF
(Rus)
Volume 28, Nº 4 (2021)
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M., Zilov A., Koteshkova O., Demidov N.
PDF
(Rus)
Volume 27, Nº 12 (2020)
Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial
Shkurova N., Baranova N., Fedin A.
PDF
(Rus)
Volume 27, Nº 4 (2020)
Cranial neuropathy as a complication of diabetes mellitus
Maksimova M., Stepanchenko O.
PDF
(Rus)
Volume 26, Nº 14 (2019)
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals
Antsiferov M., Demidov N.
PDF
(Rus)
Volume 26, Nº 4 (2019)
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A., Ostroumova O., Tkacheva O.
PDF
(Rus)
Volume 26, Nº 4 (2019)
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P., Baranov V., Vorokhobina N., Shpilevaya O.
PDF
(Rus)
Nº 11 (2018)
Apelin: biological and pathophysiological effects
Dolgikh Y., Verbovoy A.
PDF
(Rus)
Nº 16 (2017)
Opportunities for prevention of changes in skin and oral mucosa in diabetes mellitus at the present stage
Verbovoy A., Sharonova L., Burakshayev S., Kotelnikova E., Smirnova T.
PDF
(Rus)
Nº 15 (2017)
Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects
Dzerve V.
PDF
(Rus)
Nº 5 (2017)
PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS
Ametov A.
PDF
(Rus)
Nº 16 (2016)
Clinical characteristics and practical aspects of the use of new basal insulin glargine 300 U/ml Toujeo SoloStar®
Antsiferov M.
PDF
(Rus)
Nº 5 (2016)
EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS
Biryukova E.
PDF
(Rus)
Nº 17 (2015)
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike
Demidov N., Zakharova S., Zav'yalov A.
PDF
(Rus)
Nº 10 (2015)
Ingibitory dipeptidilpeptidazy-4: novye vozmozhnosti effektivnogo glikemicheskogo kontrolya putem korrektsii narusheniy zhirovogo obmena u patsientov s sakharnym diabetom 2 tipa
Gusenbekova D., Ametov A., Butaeva S.
PDF
(Rus)
Nº 5 (2015)
Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa
Antsiferov M.
PDF
(Rus)
Nº 16 (2014)
Kombinirovannaya terapiya bolevoy diabeticheskoy polineyropatii: rezul'taty pilotnogo issledovaniya
Khramilin V., Andreeva V., Demidova I.
PDF
(Rus)
Nº 5 (2014)
SAKhARNYY DIABET: OT PONIMANIYa ETIOLOGII K VYBORU LEChENIYa
Kononenko I., Smirnova O.
PDF
(Rus)
Nº 5 (2014)
TERAPIYa LIRAGLUTIDOM ZNAChITEL'NO ULUChShAET KONTROL' GLIKEMII I OKAZYVAET POLOZhITEL'NOE VLIYaNIE NA SERDEChNO-SOSUDISTUYu SISTEMU PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Kudinov V., Nichitenko M., Chesnikova A.
PDF
(Rus)
Nº 16 (2013)
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.
PDF
(Rus)
Nº 5 (2013)
PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa
Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.
PDF
(Rus)
Nº 5 (2013)
REGIDRATATsIONNAYa TERAPIYa I VOZMOZhNOSTI EE KONTROLYa U PATsIENTOV S DIABETIChESKIMI KOMAMI (OBZOR LITERATURY)
Legun A., Vetsheva M.
PDF
(Rus)
Nº 16 (2012)
Mnogofaktornoe upravlenie sakharnym diabetom 2 tipa: kakovy nashi segodnyashnie vozmozhnosti
Galstyan G.
PDF
(Rus)
Nº 11 (2012)
Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya
Shilov A., Abdullaeva A.
PDF
(Rus)
Nº 3 (2012)
PLACE OF DIBCOR® IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME
Vorokhobina N., Kuznetsova A., Vorohobina N., Kuznetsova A.
Nº 3 (2012)
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
Nº 16 (2011)
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M., Antciferov M.
Nº 5 (2011)
DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS
Pogromov A., Baturova V., Pogromov A., Yu Baturova V.
Nº 3 (2011)
DIABETIC NEPHROPATHY: DOES ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MAINTAIN PRIORITY POSITION?
Fomin V., Pulin A., Saginova E., Fomun V., Pulin A., Saginova E.
Nº 16 (2010)
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y., Biryukova E.
Nº 5 (2010)
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V., Chazova I., Fomin V.
Nº 3 (2010)
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L., Nedosugova L.
Nº 17 (2009)
KLINIChESKIE NABLYuDENIYa PATsIENTOV S OSTEOPOROZOM I ENDOKRINNOY PATOLOGIEY
Belyaeva E.
Nº 11 (2009)
Peculiarities of antihypertensive therapy in metabolic syndrome and diabetes mellitus
Mychka V., Zhernakova Y., Chazova I., Michka V., Jernakova Y., Chazova I.
Nº 3 (2009)
Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?
Mkrtumyan A., Mkrtumyan A.
Volume 29, Nº 11/12 (2022)
Clinical effects of dapagliflozin in patients with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Bagriy A., Prikolota O., Prikolota A., Mikhailichenko E., Golodnikov I., Bagriy O., Kotova K.
PDF
(Rus)
Volume 29, Nº 4 (2022)
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
PDF
(Rus)
Volume 28, Nº 12 (2021)
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.
PDF
(Rus)
Volume 28, Nº 4 (2021)
Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report
Barsukov I., Demina A.
PDF
(Rus)
Volume 28, Nº 4 (2021)
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus
Ivanova M., Zhurtova I., Sizhazheva S., Gubachikova A.
PDF
(Rus)
Volume 27, Nº 12 (2020)
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T., Lomonova T.
PDF
(Rus)
Volume 27, Nº 4 (2020)
Features of the treatment of patients with type 2 diabetes mellitus and morbid obesity
Amosova M., Gurova O., Fadeev V.
PDF
(Rus)
Volume 26, Nº 14 (2019)
Statins and the risk of diabetes: an evidence-based review
Leonova M.
PDF
(Rus)
Volume 26, Nº 4 (2019)
Prevention of blindness in diabetes mellitus. From retinal laser coagulation to pharmacology
Shadrichev F., Demidova T., Grigorieva N., Kozhevnikov A.
PDF
(Rus)
Volume 26, Nº 3 (2019)
Poststroke recovery in patients with type 2 diabetes mellitus
Tanashyan M., Maksimova M., Antonova K., Raskurazhev A., Shakhparonova N., Romantsova T.
PDF
(Rus)
Nº 11 (2018)
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.
PDF
(Rus)
Nº 16 (2017)
Features of urine microflora in diabetic patients
Chikanova A., Khamnuyeva L., Karnoukhova O., Sudakova N., Tokareva N.
PDF
(Rus)
Nº 9 (2017)
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
Shishkova V.
PDF
(Rus)
Nº 5 (2017)
SELF-CONTROL OF GLYCEMIA: SHELFLIFE OF TEST STRIPS IS IMPORTANT
Biryukova E.
PDF
(Rus)
Nº 16 (2016)
Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment
Verbovoy A., Sharonova L.
PDF
(Rus)
Nº 5 (2016)
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
Kurkin D., Volotova E., Bakulin D., Lomkina E., Tyurenkov I.
PDF
(Rus)
Nº 17 (2015)
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A., Tsanava I., Verbovaya N.
PDF
(Rus)
Nº 9 (2015)
GIPERGLIKEMIYa I OSTRYY KORONARNYY SINDROM
Martynov A., Akatova E., Nikolin O., Urlaeva I.
PDF
(Rus)
Nº 20 (2014)
Opyt primeneniya Aktovegina v lechenii neyroishemicheskoy formy sindroma «diabeticheskaya stopa»
Dibirov M., Gadzhimuradov R., Khalidov O., Proshin A., Kakubava M.
PDF
(Rus)
Nº 16 (2014)
Analiz effektivnosti i bezopasnosti primeneniya otechestvennogo insulina Rinsulin NPKh v gorode Nizhniy Novgorod
Zanozina O., Sorokina Y., Lovtsova L., Borovkov N.
PDF
(Rus)
Nº 5 (2014)
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M., Koteshkova O.
PDF
(Rus)
Nº 16 (2013)
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.
PDF
(Rus)
Nº 16 (2013)
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N., Antsiferov M.
PDF
(Rus)
Nº 5 (2013)
PERSPEKTIVNYE STRATEGII V LEChENII DIABETIChESKOY POLINEVROPATII: ROL' ANTIOKSIDANTNOY TERAPII
Gur'eva I., Svetlova O.
PDF
(Rus)
Nº 5 (2013)
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.
PDF
(Rus)
Nº 3 (2012)
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V., Peterkova V.
Nº 16 (2011)
DIABETIC GASTROENTEROPATHY: THE PATHOGENESIS AND DIFFERENTIAL TREATMENT APPROACH (LITERATURE REVIEW)
Demicheva T., Demicheva T.
Nº 3 (2011)
INTENSIVE INSULIN THERAPY IN ACUTE CEREBROVASCULAR ACCIDENT
Demidova I., Makova A., Demidova I., Makova A.
Nº 3 (2011)
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E., pl?midmagidsid Y.
Nº 16 (2010)
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.
Nº 3 (2010)
Common bean (Phaseolus vulgaris L.)/
Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.
Nº 3 (2010)
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M., Antsiferov M.
Nº 17 (2009)
LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa
Petunina N.
Nº 10 (2009)
New directions of drugs Milgamma and Milgamma compositum use in the diabetes mellitus
Den'gin V., Dengin V.
Nº 3 (2009)
Diabetic foot syndrome: approaches to treatment of infection
Privol'nev V., Privolnev V.
Volume 29, Nº 11/12 (2022)
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M., Demidov N., Safronova T., Mishra O.
PDF
(Rus)
Volume 29, Nº 4 (2022)
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S., Apetova V.
PDF
(Rus)
Volume 28, Nº 12 (2021)
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.
PDF
(Rus)
Volume 28, Nº 4 (2021)
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia
Demidov N.
PDF
(Rus)
Volume 28, Nº 3 (2021)
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A., Pereverzev A., Ostroumova O., Gusenbekova D., Romanovsky R., Shatalova N.
PDF
(Rus)
Volume 27, Nº 12 (2020)
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A., Vorobyev S., Volkova A., Vorokhobina N.
PDF
(Rus)
Volume 27, Nº 4 (2020)
Is it possible to stop the diabetes epidemic?
Verbovoy A., Dolgikh Y., Verbovaya N.
PDF
(Rus)
Volume 26, Nº 14 (2019)
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O., Goloborodova I.
PDF
(Rus)
101 - 200 de 343 resultados << < 1 2 3 4 > >> 
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies